Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Phytomenadione

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44365   clinical trials with a EudraCT protocol, of which   7389   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5 result(s) found for: Phytomenadione. Displaying page 1 of 1.
    EudraCT Number: 2010-021264-14 Sponsor Protocol Number: 10-003 Start Date*: 2012-09-25
    Sponsor Name:RWTH Aachen University represented by the rector, himself represented by the dean of the Medical Faculty
    Full Title: Vitamin K1 to slow vascular calcification in hemodialysis patients. Multicenter, multinational, randomized controlled clinical trial
    Medical condition: dialysis patients
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-006238-87 Sponsor Protocol Number: 4717 Start Date*: 2010-01-22
    Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust
    Full Title: Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K
    Medical condition: Patients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022826-34 Sponsor Protocol Number: 08092010 Start Date*: 2011-04-28
    Sponsor Name:
    Full Title: Randomised trial to investigate possible differences in biological availability and effectiveness between vitamin K solution in oil and vitamin K tablets.
    Medical condition: Lowering anticoagulant effect of vitamin K antagonists in case of over-anticoagulation or pending diagnostic or therapeutic invase action.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10053755 Vitamin K antagonist LLT
    12.1 10058768 Vitamin K LLT
    12.1 10011970 Decreased INR LLT
    12.1 10037818 Raised INR LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015858-38 Sponsor Protocol Number: ACENO-K-01-2009 Start Date*: 2011-05-26
    Sponsor Name:Dr. Antonio Javier Trujillo Santos
    Full Title: Comparación de la adición de bajas dosis de vitamina K al tratamiento con acenocumarol frente al tratamiento tradicional con acenocumarol sobre la estabilidad del efecto anticoagulante y sus compli...
    Medical condition: Pacientes que precisen de anticoagulación oral con cumarinas durante al menos 3 meses, fundamentalmente son pacientes con arritmias cardíacas (sobre todo fibrilación auricular) y enfermedad tromboe...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004578-15 Sponsor Protocol Number: 01082007 Start Date*: 2008-03-03
    Sponsor Name:Dutch Heart Foundation
    Full Title: A randomised, double blind placebo controlled trial to (A) assess the optimal vitamin K dosage for supplementation, and (B) to access whether complications of anticoagulation treatment will diminis...
    Medical condition: Anti-coagulationtreatment with vitamine K antagonists.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10058768 Vitamin K LLT
    9.1 10053755 Vitamin K antagonist LLT
    9.1 10009728 Coagulation and bleeding analyses HLT
    9.1 10043607 Thrombosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Dec 11 18:05:59 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA